Endothelin-dependent vasoconstriction in human uterine artery: Application to Preeclampsia

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Dechanet, Clotilde ^a,b   Fort, Aurélie ^a   Barbero Camps, Elisabet ^a   Dechaud, Hervé ^a,b   Richard, Sylvain ^a   Virsolvy, Anne ^a  

^a UNIV MONTPELLIER   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIHYDROPYRIDINE DERIVATIVE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; HYDRALAZINE; LABETALOL; METHYLDOPA; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; ANTIHYPERTENSIVE AGENT; ENDOTHELIN; ENDOTHELIN RECEPTOR;

ADULT; ARTERY CONSTRICTION; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MUSCLE ISOMETRIC CONTRACTION; PREECLAMPSIA; UTERINE ARTERY; UTERUS CONTRACTILITY; VASODILATATION; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; PATHOPHYSIOLOGY; PREGNANCY; VASOCONSTRICTION;

ANTIHYPERTENSIVE AGENTS; DIHYDROPYRIDINES; ENDOTHELINS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, ENDOTHELIN; UTERINE ARTERY; VASOCONSTRICTION;

EID: 79551568705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016540     Document Type: Article

References (45)

1. Higgins JR, de Swiet M (2001) Blood-pressure measurement and classification in pregnancy. Lancet 357: 131-135.
2. Goldman-Wohl D, Yagel S (2002) Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol 187: 233-238.
3. Mutter WP, Karumanchi SA (2008) Molecular mechanisms of preeclampsia. Microvasc Res 75: 1-8.
4. Burton GJ, Woods AW, Jauniaux E, Kingdom JC (2009) Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30: 473-482.
5. Hawfield A, Freedman BI (2009) Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis 3: 65-73.
6. Lyall F, Myatt L (2002) The role of the placenta in pre-eclampsia-a workshop report. Placenta 23(Suppl A): S142-145.
7. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365: 785-799.
8. Clark BA, Halvorson L, Sachs B, Epstein FH (1992) Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 166: 962-968.
9. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD (1991) Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 165: 724-727.
10. Taylor RN, Varma M, Teng NN, Roberts JM (1990) Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71: 1675-1677.
11. LaMarca BD, Alexander BT, Gilbert JS, Ryan MJ, Sedeek M, et al. (2008) Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med 5(Suppl A): S133-138.
12. Nisell H, Wolff K, Hemsen A, Lindblom B, Lunell NO, et al. (1991) Endothelin, a vasoconstrictor important to the uteroplacental circulation in pre-eclampsia. J Hypertens Suppl 9: S168-169.
13. McMahon LP, Redman CW, Firth JD (1993) Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations. Clin Sci (Lond) 85: 417-424.
14. Benigni A, Orisio S, Gaspari F, Frusca T, Amuso G, et al. (1992) Evidence against a pathogenetic role for endothelin in pre-eclampsia. Br J Obstet Gynaecol 99: 798-802.
15. Murphy SR, LaMarca BB, Cockrell K, Granger JP (2010) Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 55: 394-398.
16. Duley L, Meher S, Abalos E (2006) Management of pre-eclampsia. Bmj 332: 463-468.
17. Fort A, Cordaillat M, Thollon C, Salazar G, Mechaly I, et al. (2009) New insights in the contribution of voltage-gated Na(v) channels to rat aorta contraction. PLoS One 4: e7360.
18. Bodelsson G, Sjoberg NO, Stjernquist M (1992) Contractile effect of endothelin in the human uterine artery and autoradiographic localization of its binding sites. Am J Obstet Gynecol 167: 745-750.
19. Fried G, Samuelson U (1991) Endothelin and neuropeptide Y are vasoconstrictors in human uterine blood vessels. Am J Obstet Gynecol 164: 1330-1336.
20. Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF (1994) Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89: 1203-1208.
21. Sand AE, Ostlund E, Andersson E, Fried G (1998) Endothelin-induced contractions in placental arteries is mediated by both ETA- and ETB-receptors. Acta Physiol Scand 163: 227-234.
22. Pollock DM, Keith TL, Highsmith RF (1995) Endothelin receptors and calcium signaling. Faseb J 9: 1196-1204.
23. Miwa S, Kawanabe Y, Okamoto Y, Masaki T (2005) Ca2+ entry channels involved in endothelin-1-induced contractions of vascular smooth muscle cells. J Smooth Muscle Res 41: 61-75.
24. Kublickiene KR, Wolff K, Kublickas M, Lindblom B, Lunell NO, et al. (1994) Effects of isradipine on endothelin-induced constriction of myometrial arteries in normotensive pregnant women. Am J Hypertens 7: 50S-55S.
25. Fried G, Liu YA (1994) Effects of endothelin, calcium channel blockade and EDRF inhibition on the contractility of human uteroplacental arteries. Acta Physiol Scand 151: 477-484.
26. Richard S (2005) Vascular effects of calcium channel antagonists: new evidence. Drugs 65 Suppl 2: 1-10.
27. Nylund L, Lunell NO, Lewander R, Sarby B, Thornstrom S (1984) Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the uteroplacental blood flow. Acta Obstet Gynecol Scand Suppl 118: 71-73.
28. Lunell NO, Nylund L, Lewander R, Sarby B (1982) Acute effect of an antihypertensive drug, labetalol, on uteroplacental blood flow. Br J Obstet Gynaecol 89: 640-644.
29. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS (1993) Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancyinduced hypertension. Am J Obstet Gynecol 168: 152-156.
30. Chun M, Lin HY, Henis YI, Lodish HF (1995) Endothelin-induced endocytosis of cell surface ETA receptors. Endothelin remains intact and bound to the ETA receptor. J Biol Chem 270: 10855-10860.
31. Wolff K, Kublickiene KR, Kublickas M, Lindblom B, Lunell NO, et al. (1996) Effects of endothelin-1 and the ETA receptor antagonist BQ-123 on resistance arteries from normal pregnant and preeclamptic women. Acta Obstet Gynecol Scand 75: 432-438.
32. Spence S, Anderson C, Cukierski M, Patrick D (1999) Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reprod Toxicol 13: 15-29.
33. Steiner MK, Preston IR (2008) Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension. Vasc Health Risk Manag 4: 943-952.
34. McCoy S, Baldwin K (2009) Pharmacotherapeutic options for the treatment of preeclampsia. Am J Health Syst Pharm 66: 337-344.
35. Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, et al. (1991) Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 77: 331-337.
36. Wolff K, Nisell H, Carlstrom K, Kublickiene K, Hemsen A, et al. (1996) Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. Regul Pept 67: 211-216.
37. Singh HJ, Rahman A, Larmie ET, Nila A (2001) Endothelin-l in feto-placental tissues from normotensive pregnant women and women with pre-eclampsia. Acta Obstet Gynecol Scand 80: 99-103.
38. Thaete LG, Jilling T, Synowiec S, Khan S, Neerhof MG (2007) Expression of endothelin 1 and its receptors in the hypoxic pregnant rat. Biol Reprod 77: 526-532.
39. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA (2001) Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38: 718-722.
40. Gomez O, Figueras F, Martinez JM, del Rio M, Palacio M, et al. (2006) Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 28: 802-808.
41. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, et al. (2008) Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Cmaj 178: 701-711.
42. Wimalasundera RC, Wijetunge S, Thom SM, Regan L, Hughes AD Impaired recovery of intracellular calcium and force after activation in isolated myometrial and subcutaneous resistance arteries from women with preeclampsia. J Hypertens 28: 568-574.
43. Wimalasundera RC, Thom SA, Regan L, Hughes AD (2005) Effects of vasoactive agents on intracellular calcium and force in myometrial and subcutaneous resistance arteries isolated from preeclamptic, pregnant, and nonpregnant woman. Am J Obstet Gynecol 192: 625-632.
44. Ajne G, Ahlborg G, Wolff K, Nisell H (2005) Contribution of endogenous endothelin-1 to basal vascular tone during normal pregnancy and preeclampsia. Am J Obstet Gynecol 193: 234-240.
45. Faxen M, Nisell H, Kublickiene KR (2000) Altered gene expression of endothelin-A and endothelin-B receptors, but not endothelin-1, in myometrium and placenta from pregnancies complicated by preeclampsia. Arch Gynecol Obstet 264: 143-149.